Company
Tentarix Biotherapeutics
Enabling intelligent therapies with conditionally active biologics
Also known as TENTARIX BIOTHERAPEUTICS, LP
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Legal name
- TENTARIX BIOTHERAPEUTICS, LP
- tentarix.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We create conditionally active multispecific biologics with high therapeutic index designed to reach difficult-to-treat targets
Funding snapshot
- Total raised
- $85MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series B, $35M2023-09-06
Funding rounds
- Round, 2023
- $35M2023-08-28, SEC form D sold, 5 investors
- Series A
- $50M2021-10-14, Company stated
- Round, 2020
- $8M2020-07-13, SEC form D sold, 4 investors
Loading relationship preview